Disease management article I’d like to believe: An adoring piece in the November issue of The Atlantic suggests that someone has finally figured out how to make disease management profitable. For years, the idea was that investing money in prevention upfront, especially in chronic conditions such as diabetes and heart failure, could result in both [...] Read More...
Filed under: health, Primary Care, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, consumer health, WellPoint, Design, Data Driven, digital health, Atlantic, ticker=NYSE: PFE, David Friedberg, ticker=NYSE: MRK, ticker=NYSE: NVS, CareMore, Amos Tversky, Chronic (medicine), Daniel Kahneman, Steven Levitt, ticker=NYSE: WLP